Table of Content


Introduction
Graft Versus Host Disease (GVHD) - Overview
Graft Versus Host Disease (GVHD) - Therapeutics Development
Graft Versus Host Disease (GVHD) - Therapeutics Assessment
Graft Versus Host Disease (GVHD) - Companies Involved in Therapeutics Development
Graft Versus Host Disease (GVHD) - Drug Profiles
Graft Versus Host Disease (GVHD) - Dormant Projects
Graft Versus Host Disease (GVHD) - Discontinued Products
Graft Versus Host Disease (GVHD) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Graft Versus Host Disease (GVHD), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Graft Versus Host Disease (GVHD), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Graft Versus Host Disease (GVHD) - Pipeline by AbbVie Inc, H2 2020
Graft Versus Host Disease (GVHD) - Pipeline by Adienne Pharma & Biotech, H2 2020
Graft Versus Host Disease (GVHD) - Pipeline by AltruBio Inc, H2 2020
Graft Versus Host Disease (GVHD) - Pipeline by Amgen Inc, H2 2020
Graft Versus Host Disease (GVHD) - Pipeline by AnaptysBio Inc, H2 2020
Graft Versus Host Disease (GVHD) - Pipeline by apceth Biopharma GmbH, H2 2020
Graft Versus Host Disease (GVHD) - Pipeline by ASC Therapeutics Inc, H2 2020
Graft Versus Host Disease (GVHD) - Pipeline by AstraZeneca Plc, H2 2020
Graft Versus Host Disease (GVHD) - Pipeline by Athersys Inc, H2 2020
Graft Versus Host Disease (GVHD) - Pipeline by Autolus Therapeutics Plc, H2 2020
Graft Versus Host Disease (GVHD) - Dormant Projects, H2 2020
Graft Versus Host Disease (GVHD) - Discontinued Products, H2 2020